论文部分内容阅读
白介素 11是一种具有血小板生成功效的细胞因子 ,在临床上主要用于预防非髓性恶性疾患化疗骨髓抑制时常见的继发性血小板减少症。白介素 11可以显著降低血小板减少症的发生率及严重程度 ,减少血小板输注的需要。血小板减少是肿瘤化疗病人最常见的并发症之一 ,临床上每 4例化疗
Interleukin 11 is a platelet-producing cytokine that has been used clinically to prevent secondary thrombocytopenia, which is commonly associated with myelosuppression in patients with non-myeloid malignancies. Interleukin 11 can significantly reduce the incidence and severity of thrombocytopenia and reduce the need for platelet transfusions. Thrombocytopenia is one of the most common complications of chemotherapy in patients with cancer, clinically every 4 cases of chemotherapy